GR3003745T3 - - Google Patents

Info

Publication number
GR3003745T3
GR3003745T3 GR920400168T GR920400168T GR3003745T3 GR 3003745 T3 GR3003745 T3 GR 3003745T3 GR 920400168 T GR920400168 T GR 920400168T GR 920400168 T GR920400168 T GR 920400168T GR 3003745 T3 GR3003745 T3 GR 3003745T3
Authority
GR
Greece
Prior art keywords
hydroxypropylmethylcellulose
polyvinylpyrrolidone
disclosed
pharmaceutically acceptable
active ingredient
Prior art date
Application number
GR920400168T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3003745T3 publication Critical patent/GR3003745T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920400168T 1986-11-03 1992-02-07 GR3003745T3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92630686A 1986-11-03 1986-11-03

Publications (1)

Publication Number Publication Date
GR3003745T3 true GR3003745T3 (fr) 1993-03-16

Family

ID=25453030

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400168T GR3003745T3 (fr) 1986-11-03 1992-02-07

Country Status (5)

Country Link
EP (1) EP0266707B1 (fr)
JP (1) JPS63126825A (fr)
AT (1) ATE71833T1 (fr)
DE (1) DE3776269D1 (fr)
GR (1) GR3003745T3 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2723919B2 (ja) * 1988-09-02 1998-03-09 エーザイ株式会社 環状アミン誘導体を含有する経口用医薬品組成物
IT1229856B (it) * 1989-04-20 1991-09-13 Recordati Chem Pharm Compresse a rilascio controllato contenenti flavossato.
DE4001622A1 (de) * 1990-01-20 1991-07-25 Thomae Gmbh Dr K Orale arzneimittelformen von pimobendan
DE69332081T2 (de) 1992-09-18 2003-02-06 Yamanouchi Pharmaceutical Co., Ltd. Hydrogelzubereitung mit verzögerter freisetzung
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
CN115279346A (zh) * 2020-03-09 2022-11-01 苏什玛·保罗·伯利亚 包含屈他维林或其盐的控制释放制剂
CN117045610B (zh) * 2023-08-24 2024-04-30 杭州沐源生物医药科技有限公司 一种溶出高稳定性的盐酸拉贝洛尔组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1555958A (en) * 1976-02-27 1979-11-14 Allen & Hanburys Ltd Amino hydroxyethyl salicylamides processes for their preparation and compositions containing them
GB2181053B (en) * 1985-10-01 1990-05-23 Sandoz Ltd Pharmaceutical formulations with controlled release of the active substance
FR2588188B1 (fr) * 1985-10-04 1988-01-08 Delalande Sa Comprime de sel(s) hydrosoluble(s) de cinepazide a liberation programmee et son procede de preparation

Also Published As

Publication number Publication date
EP0266707B1 (fr) 1992-01-22
EP0266707A3 (en) 1989-05-03
EP0266707A2 (fr) 1988-05-11
ATE71833T1 (de) 1992-02-15
DE3776269D1 (de) 1992-03-05
JPS63126825A (ja) 1988-05-30

Similar Documents

Publication Publication Date Title
SI0642788T1 (en) Tramadol salt containing medicaments with sustained release of the active ingredient
NO2005012I2 (no) Triptorelin og farmasoytisk akseptable salter derav
GR1002252B (en) A novel therapeutic active compound and preparation method therefore.
HUT59314A (en) Process for producing pharmaceutical composition comprising minocylcine active ingredient and suitable for a single daily administration
AU1709888A (en) Pharmaceutically active amines
NO2001009I1 (no) Kvetiapin og farmasøytisk akseptable salter derav
AU5538098A (en) A slow releasing physiologically active pharmaceutical and method of preparation thereof
IE871584L (en) Sustained release capsule.
GR3035308T3 (en) Bioadhesive pharmaceutical composition for controlled release of drugs.
EP0459666A3 (en) Medicaments against impotence
GR3005818T3 (fr)
CA2093666A1 (fr) Preparation pharmaceutique sans solvant pour administration par voie orale permettant une liberation prolongee de l'ingredient actif et methode de fabrication de ladite preparation
ITMI913170A0 (it) Composizione farmaceutica per uso oftalmico contenente un antinfiammatorio non steroideo ed un decongestionante come principi attivi
EP0266707A3 (en) Sustained release labetalol tablet
HUT48623A (en) Herbicides comprising 2,5-dihydropyrrole derivatives as active ingredient and process for producing 2,5-dihydropyrrole derivatives
GB2277915B (en) Microballs including a pharmaceutically active ingredient and a polymer
IL81232A0 (en) Pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
HK1002831B (en) Microballs including a pharmaceutically active ingredient and a polymer
ZA876845B (en) Pharmacologically active compounds and use
IT8948660A0 (it) Farmaco attivo nel ripristino della plasticita' neuronale
FI943875L (fi) 2,3,4,5-Tetrahydro-1H-3-bentsatsepiinejä ja niiden farmaseuttisesti hyväksyttäviä happoadditiosuoloja
GB8921069D0 (en) Pharmaceutically active compound,preparation and use
HUT46505A (en) Herbicides comprising pyrrolidine and alphahalogen-acetanilide derivative as active ingredient and dichloro-acetyl-oxazolidine derivative as antidote
EP0366614A3 (en) Pharmaceutically active dithioketene derivatives
ZA874979B (en) Pharmacologically active compounds and use